Live Breaking News & Updates on Biotech value fund

Stay informed with the latest breaking news from Biotech value fund on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biotech value fund and stay connected to the pulse of your community

Cidara Therapeutics Stock Jumps 13% As It Reacquires Rights To Influenza Drug

Shares of Cidara Therapeutics, Inc. (CDTX) gained over 13% on Thursday morning after the company announced it reacquired global development and commercial rights to CD388.

Bain-capital-life-sciences , Nasdaq , Biotech-value-fund , Cidara-therapeutics-inc , Johnson , Cidara-therapeutics , Cidara-therapeutics- ,

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San-diego , California , United-states , James-merson , Michael-fitzhugh , David-gollaher , Timothy-franson , Laura-tadvalkar , Ryan-spencer , Jessica-sagers , Brian-ritchie , Jeffrey-stein

Dr Boreham's Crucible: Pharmaxis

Pharmaxis might be two clinical studies away from rehabilitation, reports Tim Boreham

Perth , Western-australia , Australia , Kathleen-metters , Gary-phillips , Neil-graham , Tim-boreham , Malcolm-mccomas , Partners-biotech-value-fund , Boehringer-ingelheim , Nasdaq , Small-caps

Novamind Inc.: Novamind Reports FY2021 Financial Results and Operating Highlights

Industry-leading revenue, $6,069,247 in FY2021Total working capital of $9,680,431 to fund operationsExpanded network to six clinics and three clinical research sitesContracted for eight clinical trialsGranted

Park-city , Utah , United-states , Salt-lake-city , Canada , Netherlands , Toronto , Ontario , Canadian , Peter-thiel , Samantha-delenardo , Yaron-conforti

Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial

Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial
londonmercury.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from londonmercury.com Daily Mail and Mail on Sunday newspapers.

Germany , United-states , Canada , Toronto , Ontario , Springville , Utah , Peter-thiel , Yaron-conforti , Reid-robison , Mike-novogratz , Cedar-clinical-research

$16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial

$16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial
News provided by
Share this article
Significant participation from North American and European institutional and sophisticated investors
This capital raising enables proceeding with the Phase 2b PTSD trial in mid-2021 as planned and sees the Company well capitalised
ADELAIDE, Australia, Feb. 10, 2021 /PRNewswire/ -- Bionomics Limited (ASX: BNO,OTCQB: BNOEF, Germany: AU000000BNO5), a global, clinical stage biopharmaceutical company, is pleased to announce that it has entered into placement agreements with a number of North American and European institutional and sophisticated investors, to raise A$15,991,634. The Company used its 15% placement capacity under Listing Rule 7.1 of 110,287,132 shares.

Germany , Australia , United-states , Canada , Adelaide , South-australia , American , Christian-angermayer , Peter-thiel , Mike-novagratz , Merck-co-inc , Apeiron-investment-group-limited